FDA ‘yes’ brings SK Biopharma’s seizure drug one step closer to Europe

25th November 2019 Uncategorised 0

The company intends to file a Marketing Authorisation Application (MAA) in the first half of next year, based on Phase II and III trials.

More: FDA ‘yes’ brings SK Biopharma’s seizure drug one step closer to Europe
Source: News